Acquired haemophilia in a patient with neoplastic disease
Journal Title: OncoReview - Year 2012, Vol 2, Issue 4
Abstract
Acquired haemophilia A (AH) is a rare autoimmune disorder caused by inhibitory antibodies against coagulation factor VIII and characterized by spontaneous hemorrhage in patients with no previous personal or family history of bleeding. Morbidity and mortality are high, primarily because of bleeding and adverse effects of immune therapy. In about 12% of cases AH is secondary to malignancy,with two-thirds of associated malignancy being solid tumors. Authors present a case of a 67-year-old patient with AH who experienced several bleeding episodes, which were treated with factorVIII “by-passing agents” including activated prothrombin complex concentrates (aPCC, FEIBA) and recombinant activated factor VIIa (rVIIa, NovoSeven). The patient was resistant to many inhibitor eradication procedures. In the 8th year of follow-up severe gastrointestinal bleeding episodes occurred, diagnosed as due to small intestine tumor with hepatic metastases. The two surgical procedures have been performed, but the patient died in the postoperative period due to cardiac arrest. The postmortem histopathological examination of the small intestine tumor revealed non-Hogdkin lymphoma. The purpose of this report is to increase awareness of the possibility of AH as the reason of bleeding in patients with malignancy as well as to stress, that all invasive procedures in AH areburdened with a high risk of complications which include fatal bleedings despite adequate administration of factor VIII by-passing agents.
Authors and Affiliations
Krystyna Zawilska, Witold Kruger, Mariola Bober, Sławomir Jurek
Keywords
Related Articles
- EP ID EP53186
- DOI -
- Views 231
- Downloads 0
Rehabilitacja chorych na nowotwory układu oddechowego
Większość chorych na raka płuca ma współistniejącą przewlekłą obturacyjną chorobę płuc oraz chorobę serca. Zakres planowanego leczenia przeciwnowotworowego zawsze musi uwzględniać stan kardiologiczny i pneumonologiczny p...
“Life-saving” inappropriate implantable cardioverter-defibrillator shocks in a cancer patient
Impaired left ventricular ejection fraction (LV EF) in patients with cancer can disqualify them from targeted antineoplastic treatment. We present the case of 63-year-old male with gastric cancer treated palliatively, wi...
Invasive fungal infection in a child with Ewing’s sarcoma
Invasive fungal infection (IFI) in patients with malignant solid tumours is rare, but it highly increases the risk of cancer recurrence because of prolonged discontinuation of cancer treatment. This paper presents a case...
Cardiac amyloidosis: a hidden cause of cardiovascular complications in oncology practice
Amyloidosis is rare, but known cause of heart failure, cardiomyopathy, coronary artery disease, disorders of cardiac conduction system and valvular damage. Disease often remains undetected until it reaches an advanced st...
Early diagnostics and prevention of anthracycline-induced cardiomyopathy – the role of cardiologist
Anticancer antibiotics, anthracyclines, may cause severe left ventricle systolic dysfunction that is associated with poor clinical prognosis. In this review, we discuss the mechanisms and risk factors of anthracycline-in...